Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Ann Pharmacother. 2004 May;38(5):892-4. Epub 2004 Mar 30.

ELA-max: A new topical lidocaine formulation.

Author information

  • 1The Pediatric Research in Emergency Therapeutics Program, Division of Pediatric Emergency Medicine, Clinical Pharmacology & Toxicology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. ran.goldman@sickkids.ca

Abstract

OBJECTIVE:

To evaluate the role of a new formulation of lidocaine (ELA-max) in local anesthesia in children and compare it with the eutectic mixture of local anesthetics (EMLA).

DATA SOURCES:

Relevant literature was identified by a MEDLINE search (1966-November 2003) using the search terms ELA-max and EMLA. Bibliographies of selected articles were also examined to include all relevant investigations. The product manufacturer was contacted for inclusion of the most recent data available.

DATA SYNTHESIS:

Topical anesthesia in children is clinically challenging. ELA-max has been shown to be as effective as EMLA for venipuncture in children, but with faster onset. Adverse effects, such as transient blanching with redness and erythema, have been reported.

CONCLUSIONS:

Further investigation is needed to determine the effectiveness of ELA-max on other painful procedures in children, as well as its safety.

PMID:
15054144
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk